Summit Therapeutics, Inc. (SMMT)
16.78
-0.26
(-1.53%)
USD |
NASDAQ |
Jan 13, 09:34
Summit Therapeutics Market Cap: 12.49B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 35.21B |
| Madrigal Pharmaceuticals, Inc. | 11.53B |
| CorMedix, Inc. | 564.92M |
| Travere Therapeutics, Inc. | 2.249B |
| Viridian Therapeutics, Inc. | 3.078B |
Market Cap Related Metrics
| PEG Ratio | -0.0388 |
| Price to Book Value | 64.97 |
| Price | 16.78 |
| Earnings Yield | -7.40% |
| PEGY Ratio | -0.0388 |